Tirzepatide (40mg)

Dual GLP-1/GIP Agonist — Maximum Research Vial

Tirzepatide (40mg) is supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.

The 40mg vial provides twice the compound of the 20mg vial — same purity, same batch-verified CoA, better value per milligram, and fewer reconstitution cycles across an extended research protocol. It is the maximum-quantity Tirzepatide format we offer.

Tirzepatide is a dual incretin agonist that activates both GLP-1 and GIP receptors. Where semaglutide (Ozempic/Wegovy) acts on GLP-1 alone, Tirzepatide’s dual activity is associated with stronger outcomes in clinical research: Phase 3 SURMOUNT trials reported mean body weight reductions of up to 22.5% over 72 weeks — one of the largest figures documented in weight-management research. Tirzepatide established the dual-agonist benchmark now used to evaluate newer tri-agonist compounds like Retatrutide.

Mechanism of research interest: GLP-1 activation modulates appetite and gastric emptying; GIP activation modulates insulin sensitivity and fat metabolism. The combined signal is studied for appetite reduction, glycaemic control, and preferential fat-mass reduction.

Key Research Areas

• Fat Loss Research — Up to 22.5% body weight reduction over 72 weeks in Phase 3 trials
• Appetite Regulation — Studied for reduced food intake via gastric emptying and central appetite signalling
• Glycaemic Control — Studied for insulin sensitivity and HbA1c reduction in type 2 diabetes research
• Body Composition — Studied for preferential fat-mass reduction over lean mass
• Cardiometabolic Markers — Studied for blood pressure, cholesterol, and cardiovascular risk improvements
• Hepatic Steatosis — Emerging research on fatty liver markers and NASH-related models

Supplied as lyophilized powder, verified by HPLC and mass spectrometry. 40mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.